(Q42259740)

English

Cost-effectiveness of telaprevir in combination with pegylated interferon alpha and ribavirin in previously untreated chronic hepatitis C genotype 1 patients

scientific article published on 18 November 2013

Statements

Cost-effectiveness of telaprevir in combination with pegylated interferon alpha and ribavirin in previously untreated chronic hepatitis C genotype 1 patients (English)
18 November 2013

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit